公开(公告)号：US20230420143A1

公开(公告)日：2023-12-28

申请号：US18240190

申请日：2023-08-30

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G16H50/50 ,  G06T7/00 ,  G16B5/00 ,  G16H50/70 ,  G16H20/10

CPC classification number: G16H50/50 ,  G06T7/0012 ,  G16B5/00 ,  G16H50/70 ,  G16H20/10 ,  G06T2207/30101

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for a patient with known or suspected atherosclerotic cardiovascular disease, such as atherosclerosis.

公开(公告)号：US20230420130A1

公开(公告)日：2023-12-28

申请号：US18241718

申请日：2023-09-01

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G16H50/20 ,  G16H20/10 ,  G16H50/50 ,  G06N20/00

CPC classification number: G16H50/20 ,  G16H20/10 ,  G16H50/50 ,  G06N20/00 ,  A61B6/504

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US20230386633A1

公开(公告)日：2023-11-30

申请号：US18232138

申请日：2023-08-09

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G16H20/10 ,  G16B5/00

CPC classification number: G16H20/10 ,  G16B5/00

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-diabetic therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US11715187B2

公开(公告)日：2023-08-01

申请号：US17888826

申请日：2022-08-16

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. Buckler ,  Changguo Ji ,  Murali Ayyapillai

IPC: G06T5/50 ,  A61B6/00 ,  G06T7/00 ,  G06T7/174

CPC classification number: G06T5/50 ,  A61B6/4241 ,  A61B6/463 ,  A61B6/482 ,  A61B6/504 ,  A61B6/5247 ,  G06T7/0012 ,  G06T7/174 ,  G06T2207/10081 ,  G06T2207/10088 ,  G06T2207/10132 ,  G06T2207/20216 ,  G06T2207/20224

Abstract: Systems and methods for improving soft tissue contrast, characterizing tissue, classifying phenotype, stratifying risk, and performing multi-scale modeling aided by multiple energy or contrast excitation and evaluation are provided. The systems and methods can include single and multi-phase acquisitions and broad and local spectrum imaging to assess atherosclerotic plaque tissues in the vessel wall and perivascular space.

公开(公告)号：US11696735B2

公开(公告)日：2023-07-11

申请号：US17314758

申请日：2021-05-07

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. Buckler ,  Mark A. Buckler

IPC: G06T7/00 ,  G06K9/62 ,  G06T5/00 ,  G06T11/00 ,  A61B6/03 ,  A61B6/00 ,  G06T7/11 ,  G06V10/44 ,  G06V30/262

CPC classification number: G06T7/0012 ,  A61B6/032 ,  A61B6/463 ,  A61B6/481 ,  A61B6/504 ,  A61B6/5217 ,  A61B6/5294 ,  G06K9/6228 ,  G06K9/6267 ,  G06K9/6274 ,  G06T5/003 ,  G06T7/11 ,  G06T11/001 ,  G06V10/454 ,  G06V10/457 ,  G06V30/274 ,  A61B6/5258 ,  G06K9/6257 ,  G06T2207/10081 ,  G06T2207/10088 ,  G06T2207/10101 ,  G06T2207/10104 ,  G06T2207/10108 ,  G06T2207/10132 ,  G06T2207/20016 ,  G06T2207/20081 ,  G06T2207/20084 ,  G06T2207/20104 ,  G06T2207/30096 ,  G06T2207/30104 ,  G06V2201/03

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.

公开(公告)号：US20220415519A1

公开(公告)日：2022-12-29

申请号：US17838135

申请日：2022-06-10

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G16H50/50 ,  G16B5/00

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US20220398706A1

公开(公告)日：2022-12-15

申请号：US17888826

申请日：2022-08-16

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. BUCKLER ,  Changguo Ji ,  Murali Ayyapillai

IPC: G06T5/50 ,  A61B6/00 ,  G06T7/00 ,  G06T7/174

Abstract: Systems and methods for improving soft tissue contrast, characterizing tissue, classifying phenotype, stratifying risk, and performing multi-scale modeling aided by multiple energy or contrast excitation and evaluation are provided. The systems and methods can include single and multi-phase acquisitions and broad and local spectrum imaging to assess atherosclerotic plaque tissues in the vessel wall and perivascular space.

公开(公告)号：US20220392070A1

公开(公告)日：2022-12-08

申请号：US17890822

申请日：2022-08-18

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. BUCKLER

IPC: G06T7/00 ,  G06T7/11 ,  A61B6/00 ,  A61B8/08 ,  A61B5/02

Abstract: A system including a hierarchical analytics framework that can utilize a first set of machine learned algorithms to identify and quantify a set of biological properties utilizing medical imaging data is provided. System can segment the medical imaging data based on the quantified biological properties to delineate existence of perivascular adipose tissue. The system can also segment the medical imaging data based on the quantified biological properties to determine a lumen boundary and/or determine a cap thickness based on a minimum distance between the lumen boundary and LRNC regions.

公开(公告)号：US20220253992A1

公开(公告)日：2022-08-11

申请号：US17566439

申请日：2021-12-30

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Changguo Ji ,  Murali Ayyapillai

IPC: G06T5/50 ,  A61B6/00 ,  G06T7/174 ,  G06T7/00

Abstract: Systems and methods for improving soft tissue contrast, characterizing tissue, classifying phenotype, stratifying risk, and performing multi-scale modeling aided by multiple energy or contrast excitation and evaluation are provided. The systems and methods can include single and multi-phase acquisitions and broad and local spectrum imaging to assess atherosclerotic plaque tissues in the vessel wall and perivascular space.

公开(公告)号：US20220012877A1

公开(公告)日：2022-01-13

申请号：US17314766

申请日：2021-05-07

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Mark A. Buckler

IPC: G06T7/00 ,  G16H70/60 ,  G16H50/20 ,  G06T7/10

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.